Tetsuya Okano

3.1k total citations
96 papers, 2.5k citations indexed

About

Tetsuya Okano is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Tetsuya Okano has authored 96 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 29 papers in Pulmonary and Respiratory Medicine and 27 papers in Molecular Biology. Recurrent topics in Tetsuya Okano's work include Lung Cancer Treatments and Mutations (18 papers), Vitamin D Research Studies (12 papers) and Lung Cancer Research Studies (12 papers). Tetsuya Okano is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Vitamin D Research Studies (12 papers) and Lung Cancer Research Studies (12 papers). Tetsuya Okano collaborates with scholars based in Japan, United States and United Kingdom. Tetsuya Okano's co-authors include Akihiko Gemma, Masahiro Seike, Shoji Kudoh, Ken‐ichi Inui, R Hori, Hitoshi Maegawa, Yuji Minegishi, Akinobu Yoshimura, Rintaro Noro and Kuniko Matsuda and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Clinical Cancer Research.

In The Last Decade

Tetsuya Okano

92 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuya Okano Japan 27 1.2k 832 596 515 237 96 2.5k
Martin Highley United Kingdom 21 1.2k 1.0× 921 1.1× 518 0.9× 439 0.9× 267 1.1× 62 3.1k
Bo Jiang China 28 879 0.7× 832 1.0× 359 0.6× 722 1.4× 281 1.2× 188 2.9k
D M Peehl United States 23 1.3k 1.1× 471 0.6× 495 0.8× 826 1.6× 613 2.6× 33 3.0k
Yi Zhu China 38 1.9k 1.5× 778 0.9× 1.0k 1.7× 334 0.6× 169 0.7× 144 3.6k
Hirokazu Taniguchi Japan 30 1.4k 1.2× 1.1k 1.3× 431 0.7× 553 1.1× 900 3.8× 140 3.4k
Bin Yi China 35 1.9k 1.5× 740 0.9× 1.0k 1.7× 550 1.1× 192 0.8× 151 3.6k
Yasuo Ishida Japan 25 900 0.7× 746 0.9× 380 0.6× 259 0.5× 315 1.3× 112 3.0k
Sinéad Toomey Ireland 19 714 0.6× 494 0.6× 243 0.4× 253 0.5× 93 0.4× 66 2.0k
Maciej Szmitkowski Poland 30 1.1k 0.9× 1.3k 1.6× 1.0k 1.7× 282 0.5× 519 2.2× 209 3.3k
Hung‐Ming Lam United States 24 1.1k 0.9× 770 0.9× 494 0.8× 766 1.5× 106 0.4× 57 2.5k

Countries citing papers authored by Tetsuya Okano

Since Specialization
Citations

This map shows the geographic impact of Tetsuya Okano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Okano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Okano more than expected).

Fields of papers citing papers by Tetsuya Okano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Okano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Okano. The network helps show where Tetsuya Okano may publish in the future.

Co-authorship network of co-authors of Tetsuya Okano

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuya Okano. A scholar is included among the top collaborators of Tetsuya Okano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuya Okano. Tetsuya Okano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyanaga, Akihiko, Hajime Asahina, Satoshi Watanabe, et al.. (2023). A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non–Small Cell Lung Cancer Study: (NEJ048A/NEXUS). Clinical Lung Cancer. 24(4). 371–375. 8 indexed citations
2.
3.
Kunugi, Shinobu, et al.. (2023). Successful immunosuppressant-free treatment of a drug-induced sarcoidosis-like reaction caused by dupilumab. Respiratory Medicine Case Reports. 44. 101883–101883. 4 indexed citations
4.
Tanaka, Yuko, Tetsuya Okano, Yujin Kudo, et al.. (2019). EP1.04-26 Efficacy and Safety of Anti-PD-1 Inhibitors in Elderly Patients with Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(10). S979–S980. 2 indexed citations
5.
Okano, Tetsuya, et al.. (2018). P3.01-24 The Importance to Switch from EGFR-TKI to Cytotoxic Chemotherapy for EGFR Mutation-Positive Adenocarcinoma. Journal of Thoracic Oncology. 13(10). S876–S876. 1 indexed citations
6.
Kitamura, Kazuhiro, Masahiro Seike, Tetsuya Okano, et al.. (2013). MiR-134/487b/655 Cluster Regulates TGF-β–Induced Epithelial–Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells. Molecular Cancer Therapeutics. 13(2). 444–453. 161 indexed citations
7.
Shimokawa, Tsuneo, Masahiro Seike, Chie Soeno, et al.. (2012). Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules. British Journal of Cancer. 106(5). 867–875. 15 indexed citations
8.
9.
Ogawa, K., Robert P. Langlais, William D. McDavid, et al.. (2010). Development of a new dental panoramic radiographic system based on a tomosynthesis method. Dentomaxillofacial Radiology. 39(1). 47–53. 34 indexed citations
10.
Mizutani, Hideaki, Tetsuya Okano, Yuji Minegishi, et al.. (2010). HSP27 modulates epithelial to mesenchymal transition of lung cancer cells in a Smad-independent manner. Oncology Letters. 1(6). 1011–1016. 27 indexed citations
11.
Miyanaga, Akihiko, Akihiko Gemma, Rintaro Noro, et al.. (2008). Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model. Molecular Cancer Therapeutics. 7(7). 1923–1930. 81 indexed citations
12.
Okano, Tetsuya, Tadashi Kondo, Kiyonaga Fujii, et al.. (2007). Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma. Clinical Cancer Research. 13(3). 799–805. 49 indexed citations
13.
Yokoo, Hideki, Tadashi Kondo, Tetsuya Okano, et al.. (2007). Protein expression associated with early intrahepatic recurrence of hepatocellular carcinoma after curative surgery. Cancer Science. 98(5). 665–673. 16 indexed citations
14.
Fujii, Kazuyasu, Tadashi Kondo, Hideki Yokoo, et al.. (2006). Database of two‐dimensional polyacrylamide gel electrophoresis of proteins labeled with CyDye DIGE Fluor saturation dye. PROTEOMICS. 6(5). 1640–1653. 14 indexed citations
15.
Yoshimura, Akinobu, Akihiko Gemma, Yoko Hosoya, et al.. (2003). Increased expression of the LGALS3 (Galectin 3) gene in human non–small‐cell lung cancer. Genes Chromosomes and Cancer. 37(2). 159–164. 36 indexed citations
16.
Kubojima, Yoshitaka, et al.. (2000). Wood properties of sugi (Cryptomeria japonica D. don) planted at Gobo-zawa in the university forest in Chiba.. 243–306. 2 indexed citations
17.
Kubojima, Yoshitaka, Hiroshi Yoshihara, Masamitsu Ohta, & Tetsuya Okano. (1996). Examination of the method of measuring the shear modulus of wood baced on the Timoshenko theory of bending. Journal of the Japan Wood Research Society. 42(12). 1170–1176. 15 indexed citations
18.
Okano, Tetsuya, et al.. (1990). Bioavailability of calcium compounds as dietary calcium sources under vitamin D-deficient or -replete conditions. 64(10). 579–587. 2 indexed citations
19.
Maegawa, Hitoshi, et al.. (1989). Effect of various chemical modifiers on H+ coupled transport of cephradine via dipeptide carriers in rabbit intestinal brush-border membranes: role of histidine residues.. Journal of Pharmacology and Experimental Therapeutics. 251(2). 745–749. 30 indexed citations
20.
Ito, Satoshi, et al.. (1988). Ecological studies on the coastal Pasania edulis forests in northern Kyushu.. 42(3). 163–186. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Highley Breakdown of academic impact, for papers by Bo Jiang Breakdown of academic impact, for papers by D M Peehl Breakdown of academic impact, for papers by Yi Zhu Breakdown of academic impact, for papers by Hirokazu Taniguchi Breakdown of academic impact, for papers by Bin Yi Breakdown of academic impact, for papers by Yasuo Ishida Breakdown of academic impact, for papers by Sinéad Toomey Breakdown of academic impact, for papers by Maciej Szmitkowski Breakdown of academic impact, for papers by Hung‐Ming Lam
Rankless by CCL
2026